Section Arrow
Quote
CNXU.NASDAQ
- Conexeu Sciences Inc.
Quotes are at least 15-min delayed:2026/07/06 18:00 EDT
After Hours
Last
 10.65
-0.15 (-1.39%)
Bid
10.21
Ask
11.82
High 10.8 
Low 10.65 
Volume 19 
Regular Hours (Closed)
Last
 10.8
-0.06 (-0.55%)
Day High 
11.2 
Prev. Close
10.86 
1-M High
17.5 
Volume 
41.09K 
Bid
10.21
Ask
11.82
Day Low
10.6 
Open
10.87 
1-M Low
9.6 
Market Cap 
290.60M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 11.02 
20-SMA 12.12 
50-SMA -- 
52-W High 18.7915 
52-W Low 9.6 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.34/-0.53
Enterprise Value
290.60M
Balance Sheet
Book Value Per Share
0.27
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
LIMNLiminatus Pharma Inc0.1426+0.0001+0.07%-- 
After Hours 0.1355 -0.0071 -4.98%
RXRXRecursion Pharmaceuticals3.96+0.16+4.21%-- 
After Hours 3.96 0 0.00%
SEERSeer2.19+0.57+35.19%-- 
After Hours 2.2 +0.01 +0.46%
GOSSGossamer Bio0.1949+0.0217+12.53%-- 
After Hours 0.19 -0.0049 -2.51%
MRNAModerna81.8+2.04+2.56%-- 
After Hours 82 +0.2 +0.24%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.